Abbott paid $1.24 billion for the remaining 83.1 percent of AMO’s stock. As a final step of the acquisition, Abbott will form a short-form merger as soon as is practical. The remaining AMO stockholders will receive $22 per share as a result of the merger.
Read the Abbott news release regarding the AMO acquisition.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
